These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

811 related items for PubMed ID: 8026027

  • 1. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH.
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [Abstract] [Full Text] [Related]

  • 2. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L, Kramsch DM, Azen SP, DeMets D, DeBoer LW, Hwang I, Vailas L, Hirsch LJ, Mack WJ, DeBoer L.
    Online J Curr Clin Trials; 1992 Oct 23; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [Abstract] [Full Text] [Related]

  • 3. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.
    Alaupovic P, Mack WJ, Knight-Gibson C, Hodis HN.
    Arterioscler Thromb Vasc Biol; 1997 Apr 23; 17(4):715-22. PubMed ID: 9108785
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression.
    Mack WJ, Krauss RM, Hodis HN.
    Arterioscler Thromb Vasc Biol; 1996 May 23; 16(5):697-704. PubMed ID: 8963728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
    Syvänne M, Nieminen MS, Frick MH, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Ehnholm C, Taskinen MR.
    Circulation; 1998 Nov 10; 98(19):1993-9. PubMed ID: 9808595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR, Waters D, Havel RJ.
    Circulation; 1993 Dec 10; 88(6):2762-70. PubMed ID: 8252689
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N, Ramires JA.
    Arq Bras Cardiol; 1991 Sep 10; 57(3):253-61. PubMed ID: 1824203
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).
    Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, DeBoer LW, Mahrer PR, Masteller MJ, Vailas LI, Alaupovic P, Hirsch LJ, MARS Research Group.
    Ann Intern Med; 1993 Nov 15; 119(10):969-76. PubMed ID: 8214993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.